Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2024-10-16 (iex.nl)
Unilever leads on green Damrak, Pharming -8%
Shortly after the gong on Thursday, the AEX index was half a percent higher at 894.97 points, while the Midkap also gained half a percent.
Read more
2024-10-16 (iex.nl)
Unilever leads on green Damrak, Pharming -8%
Shortly after the gong on Thursday, the AEX index was half a percent higher at 894.97 points, while the Midkap also gained half a percent.
Read more
2024-09-27 (iex.nl)
Final call: BAM and Pharming are in great demand on green-colored Damrak
The AEX closed 0.6% higher, good for a weekly gain of 2.2%. And furthermore: PCE inflation, Pharming, BAM, Flow Traders and we are already looking ahead to the coming stock market week.
Read more
2024-09-27 (iex.nl)
Final call: BAM and Pharming are in great demand on green-colored Damrak
The AEX closed 0.6% higher, good for a weekly gain of 2.2%. And furthermore: PCE inflation, Pharming, BAM, Flow Traders and we are already looking ahead to the coming stock market week.
Read more
2024-09-26 (iex.nl)
British green light for Joenja from Pharming
Pharming has received market approval from the British regulator MHRA for the sale of its drug Joenja for the treatment of APDS, a rare and progressive primary immune system disorder. That made the biopharmaceutical bed...
Read more